Presbyterian Health Foundation awards $3.7 million in medical research grants

Published: Tuesday, July 18, 2017 5:00 am By: Staff Reports Source: The Oklahoman

More than 30 research and clinical projects, as well as scientific equipment and a researcher recruitment package, will be funded from $3.73 million in grants announced Monday by Oklahoma City's Presbyterian Health Foundation.

The grants will go to the University of Oklahoma Health Sciences Center and the Oklahoma Medical Research Foundation. The grant award categories include seed projects, bridge funding, scientific equipment and recruiting assistance.


"As biomedical research grants become exceedingly difficult to receive from the National Institutes of Health and other organizations, it is exciting for Presbyterian Health Foundation to be at the forefront and begin filling that gap," said PHF President Tom R. Gray III. "These grants will increase the research dollars going to experienced and emerging scientists at OUHSC and OMRF and will allow Oklahoma researchers to continue their important work. It will also support them as they pursue medical discoveries and future funding opportunities."

More than two-thirds of the grants — $2.65 million — will go to the OU Health Sciences Center for research on cancer, stroke, obesity, aging and heart disease, as well as scientific equipment. Grants were awarded to senior-level scientists and clinicians, who often collaborate in teams, as well as faculty who are in the early stages of their careers.

"Investments from PHF tremendously accelerate and enhance our OUHSC research programs," said Jason Sanders, senior vice president and provost at OU Health Sciences Center. "The funding is vital in helping our researchers take their investigations to the next stage of discovery."

One OU Health Sciences Center project focuses on communication among nerve cells in the aging brain, as well as information processing and memory function in the nervous system. Researchers hope to achieve progress in the early diagnosis and treatment of diseases like dementia and Alzheimer's.

Read the full article at

Back to top